Lipoprotein(a) and Metabolic Syndrome (2022)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.3238/arztebl.m2022.0153
- Subjects: ESTRÓGENOS; ESTUDOS DE COORTE; REPOSIÇÃO HORMONAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Deutsches arzteblatt international
- ISSN: 1866-0452
- Volume/Número/Paginação/Ano: v. 119, n. 15, p. 270-+, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BUCHMANN, Nikolaus et al. Lipoprotein(a) and Metabolic Syndrome. Deutsches arzteblatt international, v. 119, n. 15, p. 270-+, 2022Tradução . . Disponível em: https://doi.org/10.3238/arztebl.m2022.0153. Acesso em: 24 jan. 2026. -
APA
Buchmann, N., Ittermann, T., Demuth, I., Markus, M. R. P., Voelzke, H., Doerr, M., et al. (2022). Lipoprotein(a) and Metabolic Syndrome. Deutsches arzteblatt international, 119( 15), 270-+. doi:10.3238/arztebl.m2022.0153 -
NLM
Buchmann N, Ittermann T, Demuth I, Markus MRP, Voelzke H, Doerr M, Friedrich N, Lerch MM, Santos Filho RD dos, Schipf S. Lipoprotein(a) and Metabolic Syndrome [Internet]. Deutsches arzteblatt international. 2022 ; 119( 15): 270-+.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3238/arztebl.m2022.0153 -
Vancouver
Buchmann N, Ittermann T, Demuth I, Markus MRP, Voelzke H, Doerr M, Friedrich N, Lerch MM, Santos Filho RD dos, Schipf S. Lipoprotein(a) and Metabolic Syndrome [Internet]. Deutsches arzteblatt international. 2022 ; 119( 15): 270-+.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3238/arztebl.m2022.0153 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.3238/arztebl.m2022.0153 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
